<SEC-DOCUMENT>0001193125-25-123366.txt : 20250521
<SEC-HEADER>0001193125-25-123366.hdr.sgml : 20250521
<ACCEPTANCE-DATETIME>20250520201542
ACCESSION NUMBER:		0001193125-25-123366
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250520
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250521
DATE AS OF CHANGE:		20250520

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		25970615

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d933207d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bhc="http://www.bauschhealth.com/20250520" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_DocumentPeriodEndDate" name="dei:DocumentPeriodEndDate" contextRef="duration_2025-05-20_to_2025-05-20">2025-05-20</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2025-05-20_to_2025-05-20" name="dei:EntityCentralIndexKey" contextRef="duration_2025-05-20_to_2025-05-20">0000885590</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2025-05-20_to_2025-05-20" name="dei:AmendmentFlag" contextRef="duration_2025-05-20_to_2025-05-20">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="bhc-20250520.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-05-20_to_2025-05-20"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000885590</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-20</xbrli:startDate> <xbrli:endDate>2025-05-20</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style=" -sec-ix-hidden:Hidden_dei_DocumentPeriodEndDate" id="Fact_0">MAY 20, 2025</span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityRegistrantName" id="ixv-294">Bausch Health Companies Inc.</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="ixv-295">British Columbia</ix:nonNumeric>, Canada</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityFileNumber" id="ixv-296">001-14956</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityTaxIdentificationNumber" id="ixv-297">98-0448205</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">file number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityAddressAddressLine1" id="ixv-298">2150 St. Elz&#233;ar Blvd. West</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityAddressCityOrTown" id="ixv-299">Laval</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="ixv-300">Qu&#233;bec</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="ixv-301">Canada</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityAddressPostalZipCode" id="ixv-302">H7L&#160;4A8</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_2">514</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_3">744-6792</ix:nonNumeric></span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="ixv-305">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="ixv-306">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="ixv-307">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="ixv-308">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:27%"/>
<td style="vertical-align:bottom"/>
<td style="width:24%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>
<td style="vertical-align:bottom"/>
<td style="width:21%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_4">Common Shares, No Par Value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_5">BHC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-05-20_to_2025-05-20" format="ixt-sec:exchnameen" id="Fact_6">New York Stock Exchange</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">Toronto Stock Exchange</td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric contextRef="duration_2025-05-20_to_2025-05-20" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-312">&#9744;</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01.</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement.</p></td></tr> </table><p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;20, 2025, Bausch Health Companies Inc. (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;) entered into respective letter agreements (the &#8220;<span style="text-decoration:underline">Letter Agreements</span>&#8221; and each a &#8220;<span style="text-decoration:underline">Letter Agreement</span>&#8221;) with each of (i)&#160;Carl Icahn&#160;and the other members of the Icahn Group (as such term is defined in the Director Appointment and Nomination Agreement dated February&#160;23, 2021 between the Company and the persons and entities listed on Schedule A thereto (the &#8220;<span style="text-decoration:underline">Company DANA</span>&#8221;)), (ii) John Paulson and his affiliates (the &#8220;<span style="text-decoration:underline">Paulson Group</span>&#8221;) and (iii)&#160;Sarah Kavanagh and her affiliates (the &#8220;<span style="text-decoration:underline">Kavanagh Group</span>&#8221;, and each of the Icahn Group, the Paulson Group and the Kavanagh Group, a &#8220;<span style="text-decoration:underline">Group</span>&#8221;), as overlapping directors on the Board of Directors of the Company (the &#8220;<span style="text-decoration:underline">BHC Board</span>&#8221;) and the Board of Directors of Bausch + Lomb Corporation (&#8220;<span style="text-decoration:underline">B+L</span>&#8221; and the Board, the &#8220;<span style="text-decoration:underline">B+L Board</span>&#8221;). Pursuant to the respective Letter Agreements, each of the Groups, respectively, have agreed that, if such Group engages in a &#8220;Specified Action&#8221; then such Group shall immediately tender their resignations from the BHC Board and the B+L Board, and (ii)&#160;in respect of the Icahn Group Letter Agreement, the Icahn Group shall irrevocably waive its rights under specified provisions of the Amended and Restated Director Appointment and Nomination Agreement dated June&#160;21, 2022 between B+L and certain members of the Icahn Group (the &#8220;<span style="text-decoration:underline">B+L DANA</span>&#8221;), including the right to designate a Replacement Designee (as such term is defined in the B+L DANA).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under each Letter Agreement, respectively, so long as no member of such Group has engaged in a Specified Action, the Company has agreed (i)&#160;if such person or member of such Group (each a &#8220;<span style="text-decoration:underline">Group Designee</span>&#8221;) is named as a management nominee for election to the B+L Board at any meeting of shareholders of B+L, then the Company shall vote (or cause to be voted) all voting securities of B+L owned or controlled by the Company for each such Group Designee, and (ii)&#160;such Group Designee will also have the right to be appointed to any newly-created committees of the BHC Board, absent actual conflicts of interest.</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in each Letter Agreement, &#8220;Specified Actions&#8221; include any of the following: (i)&#160;knowingly instigating or supporting any proxy contest against the Company regarding any matter; (ii)&#160;presenting (or requesting to present) at any meeting of the Company&#8217;s shareholders any proposal for consideration for action by shareholders or engaging in any solicitation of proxies or consents; (iii)&#160;granting any proxy, consent or other authority to vote with respect to any matters or depositing any voting securities in a voting trust or subjecting them to a voting agreement (subject to certain exceptions); (iv) seeking, or encouraging any person, to submit nominations in furtherance of a contested solicitation for the election or removal of directors of the Company; or (v)&#160;acquiring, offering or proposing to acquire any voting securities or rights to acquire any voting securities that would result in the Icahn Group beneficially owning more than 19.99% of then outstanding common shares of the Company (subject to certain exceptions).</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Letter Agreements is qualified in its entirety by reference to the full text of each Letter Agreement, a copy of each of which is attached hereto as an Exhibit and is incorporated by reference herein.</p></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit&#160;No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/885590/000088559021000008/ex101-q4x2020.htm">Director Nomination and Appointment Agreement by and among Bausch Health Companies Inc., Carl C. Icahn and the persons and entities listed therein, dated February 23, 2021, originally filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 24, 2021, which is incorporated reference herein.</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d933207dex102.htm">Letter Agreement by and among Bausch Health Companies Inc., Carl C. Icahn and the persons and entities listed therein, dated May&#160;20,&#160;2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d933207dex103.htm">Letter Agreement by and among Bausch Health Companies Inc. and John Paulson, dated May 20, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d933207dex104.htm">Letter Agreement by and among Bausch Health Companies Inc., Sarah Kavanagh, dated May 20, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr></table><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed herewith.</p></td></tr></table></div></div><p style="page-break-before:always"></p> <hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p><p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May&#160;20, 2025</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">
<tr>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">BAUSCH HEALTH COMPANIES INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Seana Carson</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Seana Carson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, General Counsel</td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>d933207dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Execution Version [Conformed] </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>DELIVERED BY <FONT STYLE="white-space:nowrap">E-MAIL</FONT> </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;20<B>,</B> 2025 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brett Icahn </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Icahn Capital LP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16690 Collins Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penthouse Suite Sunny Isles Beach </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FL 33160 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mr.&nbsp;Icahn: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Supplemental Letter Agreement
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further to our discussions and the meeting of the board of directors (the <B>BHCI Board</B>) of Bausch Health Companies Inc. (the <B>Company</B>)
held yesterday, this letter agreement sets forth certain agreements between the Company and the Icahn Group (as such term is defined in the Director Appointment and Nomination Agreement dated February&nbsp;23, 2021 (the <B>BHCI DANA</B>) between the
Company and the persons and entities listed on Schedule A thereto (collectively, the <B>Icahn Group</B>)) regarding the matters discussed herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the parties hereto, the parties agree: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for purposes of this letter agreement: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>B+L</B>&#148; means Bausch + Lomb Corporation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>B+L Board</B>&#148; means the board of directors of B+L; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>B+L DANA</B>&#148; means the Amended and Restated Director Appointment and Nomination Agreement dated
June&nbsp;21, 2022 between B+L and certain members of the Icahn Group; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>B+L Icahn Designees</B>&#148; means the Icahn Designees (as such term is defined in B+L DANA); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>BHCI Icahn Designees</B>&#148; means the Icahn Designees (as such term is defined in the BHCI DANA;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that should any member of the Icahn Group engage in a Specified Action (as such term is defined below):
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) any B+L Icahn Designee then serving on the BHCI Board shall immediately tender his or her resignation from
the BHCI Board; and (ii)&nbsp;the Icahn Group shall irrevocably waive in writing all of its rights and entitlements under sections 1(a)(v) and 1(a)(vii) of the BHCI DANA, including, for the avoidance of doubt, any right to designate a Replacement
Designee (as such term is defined in the BHCI DANA) for an Icahn Designee that has tendered his or her resignation in accordance with Section&nbsp;2(a)(i) hereof; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) any B+L Icahn Designee then serving on the board of directors of B+L (the <B>B+L Board</B>) shall
immediately tender his or her resignation from the B+L Board; and (ii)&nbsp;the Icahn Group shall irrevocably waive in writing all of its rights and entitlements under sections 1(a)(iv), 1(a)(vi) and 1(e) of the B+L DANA, including, for the
avoidance of doubt, any right to designate a Replacement Designee (as such term is defined in the B+L DANA) for an Icahn Designee that has tendered his or her resignation in accordance with Section&nbsp;2(b)(i) hereof; and </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as long as no member of the Icahn Group has engaged in a Specified Action: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will support any B+L Icahn Designee who is then named as a management nominee for election to the
B+L Board and shall vote (or cause to be voted), in respect of any meeting of shareholders of B+L at which an election of directors is held, all voting securities of B+L of which it, directly or indirectly, has ownership or over which it exercises
control or direction, in each case that are entitled to be voted at such meeting, in favour of each such B+L Icahn Designee; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the BHCI Board shall not form any new committee (other than committees formed solely for the purposes of
addressing matters for which there are actual conflicts of interest involving the BHCI Icahn Designees) without offering to at least one BHCI Icahn Designee the opportunity to be a member of such committee (provided, however, that if such committee
has more than five (5)&nbsp;members then both BHCI Icahn Designees shall be offered to be appointed to such committee (to the extent there are two BHCI Icahn Designees then on the BHCI Board)). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BHCI represents and warrants to the Icahn Group that it has entered into agreements in respect of each of the members of the BHCI Board that are also members
of the B+L Board and nominees for election to the B+L Board (a <B>Dual Nominee</B>) and copies of such agreements are attached hereto (the <B>Dual Nominee Agreements</B>). If, following the execution of this letter agreement, any Dual Nominee
Agreement is terminated (other than by virtue of a director&#146;s resignation from the BHCI Board) or modified, then such termination or modification shall be simultaneously offered to the Icahn Group. For the avoidance of doubt, the provisions of
this paragraph apply solely in respect of this letter agreement and not any other agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, &#147;Specified Actions&#148;
means any of the following actions taken following the date hereof (other than in a BHCI Icahn Designee&#146;s capacity as a director of the Company on behalf of the BHCI Board): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">knowingly instigate or support any proxy contest in any way against the Company regarding any matter, including
the election of directors at any annual general meeting or special meeting of the Company&#146;s stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">present (or request to present) at any annual general meeting or any special meeting of the Company&#146;s
stockholders, any proposal for consideration for action by stockholders or engage in any solicitation of proxies or consents or become a &#147;participant&#148; in a &#147;solicitation&#148; (as such terms are defined in Regulation 14A under the
Securities Exchange Act of 1934, as amended) of proxies or consents (including, without limitation, any solicitation of consents that seeks to call a special meeting of stockholders of the Company); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">grant any proxy, consent or other authority to vote with respect to any matters (other than to the named
proxies included in the Company&#146;s proxy card for any annual general meeting or special meeting of stockholders) or deposit any voting securities in a voting trust or subject them to a voting agreement or other arrangement of similar effect
(excluding customary brokerage accounts, margin accounts, prime brokerage accounts and the like); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">seek, or directly encourage any person, to submit nominations in furtherance of a &#147;contested
solicitation&#148; for the election or removal of directors with respect to the Company or, except as expressly provided in this Agreement, seek, encourage or take any other action with respect to the election or removal of any directors of the
Company; or </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">acquire, offer or propose to acquire any voting securities or rights to acquire any voting securities if after
the taking of any such action, the undersigned would, in aggregate, beneficially own more than 19.99% of the then outstanding common shares of the Company (provided that the foregoing does not apply to securities that were acquired directly from the
Company by the undersigned as or pursuant to director compensation for serving as a director of the Company). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the parties
hereto represents and warrants that: (a)&nbsp;it has the power, capacity and authority to execute, deliver and carry out the terms and provisions of this letter agreement and to consummate the transactions contemplated hereby; and (b)&nbsp;this
letter agreement has been duly authorized, executed and delivered by it and constitutes a legal, valid and binding obligation enforceable against it in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the parties hereto recognizes and agrees that if for any reason any of the provisions of this letter agreement are not performed in accordance with
their specific terms or are otherwise breached, immediate and irreparable harm or injury would be caused for which money damages would not be an adequate remedy. Accordingly, the parties agree that in addition to other remedies the other party shall
be entitled to at law or equity, the other party shall be entitled to an injunction or injunctions to prevent breaches of this letter agreement and to enforce specifically the terms and provisions of this letter agreement. In the event that any
action shall be brought in equity to enforce the provisions of this letter agreement, no party shall allege, and each party hereby waives the defense, that there is an adequate remedy at law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties hereby agree to maintain, and to cause their respective representatives, to maintain, the confidentiality of the negotiation of this letter
agreement and related matters which have not previously been made public, and no party shall disclose any information relating to the foregoing except as required by law, regulation or rules of any applicable stock exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS
EXECUTED AND TO BE PERFORMED WHOLLY WITHIN SUCH STATE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter agreement may be
executed (including by facsimile or PDF) in two or more counterparts which together shall constitute a single agreement. This letter agreement shall not be assignable by any of the parties to this agreement. This letter agreement, however, shall be
binding on successors of the parties hereto. This letter agreement shall terminate and be of no further force or effect upon the resignation of the BHCI Icahn Designees from the BHCI Board; provided, however, that Sections 2 and 3(a) hereof shall
survive until the next annual meeting of the shareholders of B+L to be held following such resignation from the BHCI Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the terms of this letter
agreement are in accordance with your understandings, please sign and return this letter agreement to the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yours very truly, </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BAUSCH HEALTH COMPANIES INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Seana Carson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Seana Carson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Vice President, General Counsel</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACKNOWLEDGED AND AGREED TO</B>, as of the date first above written. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>CARL C. ICAHN</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carl C. Icahn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Carl C. Icahn</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>BRETT ICAHN</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brett Icahn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brett Icahn</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>STEVEN MILLER</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven Miller</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven Miller</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN PARTNERS LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jesse Lynn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jesse Lynn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN PARTNERS MASTER FUND LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jesse Lynn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jesse Lynn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN ENTERPRISES G.P. INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ted Papapostolou</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Ted Papapostolou</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN ENTERPRISES HOLDINGS L.P., by its general partner, Icahn Enterprises G.P. Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ted Papapostolou</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Ted Papapostolou</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>IPH GP LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ted Papapostolou</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Ted Papapostolou</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN CAPITAL LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jesse Lynn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jesse Lynn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN ONSHORE LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jesse Lynn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jesse Lynn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ICAHN OFFSHORE LP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jesse Lynn</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jesse Lynn</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Operating Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BECKTON CORP.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ted Papapostolou</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Ted Papapostolou</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>d933207dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Execution Version [Conformed] </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>DELIVERED BY <FONT STYLE="white-space:nowrap">E-MAIL</FONT> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;20<B>,</B> 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John Paulson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mr.&nbsp;Paulson: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Letter Agreement </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further to the meeting of the
board of directors (the <B>BHCI Board</B>) of Bausch Health Companies Inc. (the <B>Company</B>) held yesterday, this letter agreement sets forth certain agreements between you and the Company regarding the matters discussed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the parties hereto, the parties agree: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for purposes of this letter agreement: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>B+L</B>&#148; means Bausch + Lomb Corporation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>B+L Board</B>&#148; means the board of directors of B+L; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that should you or your affiliate, including Paulson&nbsp;&amp; Co., Inc., engage in a Specified Action (as
such term is defined below), you shall immediately tender your resignation from both the BHCI Board and the B+L Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as long as neither you nor your affiliate, including Paulson&nbsp;&amp; Co., Inc., has engaged in a Specified
Action: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will support you if you are named as a management nominee for election to the B+L Board and shall
vote (or cause to be voted), in respect of any meeting of shareholders of B+L at which an election of directors is held, all voting securities of B+L of which it, directly or indirectly, has ownership or over which it exercises control or direction,
in each case that are entitled to be voted at such meeting, in your favour; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the BHCI Board shall not form any new committee (other than committees formed solely for the purposes of
addressing matters for which there are actual conflicts of interest involving you) without offering you the opportunity to be a member of such committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BHCI represents and warrants that it has entered into agreements in respect of each of the members of the BHCI Board that are also members of the B+L Board
and nominees for election to the B+L Board (a <B>Dual Nominee</B>) and copies of such agreements are attached hereto (the <B>Dual Nominee Agreements</B>). If, following the execution of this letter agreement, any Dual Nominee Agreement is terminated
(other than by virtue of such director&#146;s resignation from the BHCI Board) or modified, then such termination or modification shall be simultaneously offered to you. For the avoidance of doubt, the provisions of this paragraph apply solely in
respect of this letter agreement and not any other agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, &#147;Specified Actions&#148; means any of the following actions taken
following the date hereof (other than in your capacity as a director of the Company on behalf of the BHCI Board): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">knowingly instigate or support any proxy contest in any way against the Company regarding any matter, including
the election of directors at any annual general meeting or special meeting of the Company&#146;s stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">present (or request to present) at any annual general meeting or any special meeting of the Company&#146;s
stockholders, any proposal for consideration for action by stockholders or engage in any solicitation of proxies or consents or become a &#147;participant&#148; in a &#147;solicitation&#148; (as such terms are defined in Regulation 14A under the
Securities Exchange Act of 1934, as amended) of proxies or consents (including, without limitation, any solicitation of consents that seeks to call a special meeting of stockholders of the Company); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">grant any proxy, consent or other authority to vote with respect to any matters (other than to the named
proxies included in the Company&#146;s proxy card for any annual general meeting or special meeting of stockholders) or deposit any voting securities in a voting trust or subject them to a voting agreement or other arrangement of similar effect
(excluding customary brokerage accounts, margin accounts, prime brokerage accounts and the like); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">seek, or knowingly encourage any person, to submit nominations in furtherance of a &#147;contested
solicitation&#148; for the election or removal of directors with respect to the Company or, except as expressly provided in this Agreement, seek, encourage or take any other action with respect to the election or removal of any directors of the
Company; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">acquire, offer or propose to acquire any voting securities or rights to acquire any voting securities if after
the taking of any such action, the undersigned would, in aggregate, beneficially own more than 19.99% of the then outstanding common shares of the Company (provided that the foregoing does not apply to securities that were acquired directly from the
Company by the undersigned as or pursuant to director compensation for serving as a director of the Company). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the parties
hereto represents and warrants that: (a)&nbsp;it has the power, capacity and authority to execute, deliver and carry out the terms and provisions of this letter agreement and to consummate the transactions contemplated hereby; and (b)&nbsp;this
letter agreement has been duly authorized, executed and delivered by it and constitutes a legal, valid and binding obligation enforceable against it in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the parties hereto recognizes and agrees that if for any reason any of the provisions of this letter agreement are not performed in accordance with
their specific terms or are otherwise breached, immediate and irreparable harm or injury would be caused for which money damages would not be an adequate remedy. Accordingly, the parties agree that in addition to other remedies the other party shall
be entitled to at law or equity, the other party shall be entitled to an injunction or injunctions to prevent breaches of this letter agreement and to enforce specifically the terms and provisions of this letter agreement. In the event that any
action shall be brought in equity to enforce the provisions of this letter agreement, no party shall allege, and each party hereby waives the defense, that there is an adequate remedy at law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties hereby agree to maintain, and to cause their respective representatives, to maintain, the confidentiality of the negotiation of this letter
agreement and related matters which have not previously been made public, and no party shall disclose any information relating to the foregoing except as required by law, regulation or rules of any applicable stock exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS
EXECUTED AND TO BE PERFORMED WHOLLY WITHIN SUCH STATE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter agreement may be executed (including by facsimile or PDF) in two or more counterparts which
together shall constitute a single agreement. This letter agreement shall not be assignable by any of the parties to this agreement. This letter agreement, however, shall be binding on successors of the parties hereto. This letter agreement shall
terminate and be of no further force or effect upon your resignation from the BHCI Board; provided, however, that Sections 2 and 3(a) hereof shall survive until the next annual meeting of the shareholders of B+L to be held following such resignation
from the BHCI Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the terms of this letter agreement are in accordance with your understandings, please sign and return this letter agreement to
the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yours very truly, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BAUSCH HEALTH COMPANIES INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Per:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Seana Carson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Seana Carson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Executive Vice President, General Counsel</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACKNOWLEDGED AND AGREED TO</B>, as of the date first above written. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>JOHN PAULSON</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Paulson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John Paulson</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>d933207dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Execution Version [Conformed]</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>DELIVERED BY <FONT STYLE="white-space:nowrap">E-MAIL</FONT> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;20<B>,</B> 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sarah B. Kavanagh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Director </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Ms.&nbsp;Kavanagh: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Letter Agreement </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further to the meeting of the
board of directors (the <B>BHCI Board</B>) of Bausch Health Companies Inc. (the <B>Company</B>) held yesterday, this letter agreement sets forth certain agreements between you and the Company regarding the matters discussed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the parties hereto, the parties agree: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for purposes of this letter agreement: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>B+L</B>&#148; means Bausch + Lomb Corporation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>B+L Board</B>&#148; means the board of directors of B+L; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that should you engage in a Specified Action (as such term is defined below), you shall immediately tender your
resignation from both the BHCI Board and the B+L Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as long as you have not engaged in a Specified Action: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will support you if you are named as a management nominee for election to the B+L Board and shall
vote (or cause to be voted), in respect of any meeting of shareholders of B+L at which an election of directors is held, all voting securities of B+L of which it, directly or indirectly, has ownership or over which it exercises control or direction,
in each case that are entitled to be voted at such meeting, in your favour; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the BHCI Board shall not form any new committee (other than committees formed solely for the purposes of
addressing matters for which there are actual conflicts of interest involving you) without offering you the opportunity to be a member of such committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BHCI represents and warrants that it has entered into agreements in respect of each of the members of the BHCI Board that are also members of the B+L Board
and nominees for election to the B+L Board (a <B>Dual Nominee</B>) and copies of such agreements are attached hereto (the <B>Dual Nominee Agreements</B>). If, following the execution of this letter agreement, any Dual Nominee Agreement is terminated
(other than by virtue of such director&#146;s resignation from the BHCI Board) or modified, then such termination or modification shall be simultaneously offered to you. For the avoidance of doubt, the provisions of this paragraph apply solely in
respect of this letter agreement and not any other agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing, &#147;Specified Actions&#148; means any of the following
actions taken following the date hereof (other than in your capacity as a director of the Company on behalf of the BHCI Board): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">knowingly instigate or support any proxy contest in any way against the Company regarding any matter, including
the election of directors at any annual general meeting or special meeting of the Company&#146;s stockholders; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">present (or request to present) at any annual general meeting or any special meeting of the Company&#146;s
stockholders, any proposal for consideration for action by stockholders or engage in any solicitation of proxies or consents or become a &#147;participant&#148; in a &#147;solicitation&#148; (as such terms are defined in Regulation 14A under the
Securities Exchange Act of 1934, as amended) of proxies or consents (including, without limitation, any solicitation of consents that seeks to call a special meeting of stockholders of the Company); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">grant any proxy, consent or other authority to vote with respect to any matters (other than to the named
proxies included in the Company&#146;s proxy card for any annual general meeting or special meeting of stockholders) or deposit any voting securities in a voting trust or subject them to a voting agreement or other arrangement of similar effect
(excluding customary brokerage accounts, margin accounts, prime brokerage accounts and the like); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">seek, or knowingly encourage any person, to submit nominations in furtherance of a &#147;contested
solicitation&#148; for the election or removal of directors with respect to the Company or, except as expressly provided in this Agreement, seek, encourage or take any other action with respect to the election or removal of any directors of the
Company; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">acquire, offer or propose to acquire any voting securities or rights to acquire any voting securities if after
the taking of any such action, the undersigned would, in aggregate, beneficially own more than 19.99% of the then outstanding common shares of the Company (provided that the foregoing does not apply to securities that were acquired directly from the
Company by the undersigned as or pursuant to director compensation for serving as a director of the Company). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the parties
hereto represents and warrants that: (a)&nbsp;it has the power, capacity and authority to execute, deliver and carry out the terms and provisions of this letter agreement and to consummate the transactions contemplated hereby; and (b)&nbsp;this
letter agreement has been duly authorized, executed and delivered by it and constitutes a legal, valid and binding obligation enforceable against it in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the parties hereto recognizes and agrees that if for any reason any of the provisions of this letter agreement are not performed in accordance with
their specific terms or are otherwise breached, immediate and irreparable harm or injury would be caused for which money damages would not be an adequate remedy. Accordingly, the parties agree that in addition to other remedies the other party shall
be entitled to at law or equity, the other party shall be entitled to an injunction or injunctions to prevent breaches of this letter agreement and to enforce specifically the terms and provisions of this letter agreement. In the event that any
action shall be brought in equity to enforce the provisions of this letter agreement, no party shall allege, and each party hereby waives the defense, that there is an adequate remedy at law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties hereby agree to maintain, and to cause their respective representatives, to maintain, the confidentiality of the negotiation of this letter
agreement and related matters which have not previously been made public, and no party shall disclose any information relating to the foregoing except as required by law, regulation or rules of any applicable stock exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS
EXECUTED AND TO BE PERFORMED WHOLLY WITHIN SUCH STATE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter agreement may be
executed (including by facsimile or PDF) in two or more counterparts which together shall constitute a single agreement. This letter agreement shall not be assignable by any of the parties to this agreement. This letter agreement, however, shall be
binding on successors of the parties hereto. This letter agreement shall terminate and be of no further force or effect upon your resignation from the BHCI Board; provided, however, that Sections 2 and 3(a) hereof shall survive until the next annual
meeting of the shareholders of B+L to be held following such resignation from the BHCI Board. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the terms of this letter agreement are in accordance with your understandings, please sign and return
this letter agreement to the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yours very truly, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BAUSCH HEALTH COMPANIES INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Seana Carson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Seana Carson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Executive Vice President, General Counsel</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ACKNOWLEDGED AND AGREED TO</B>, as of the date first above written. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SARAH B. KAVANAGH</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Sarah B. Kavanagh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sarah B. Kavanagh</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>bhc-20250520.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 5/20/2025 6:51:12 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:bhc="http://www.bauschhealth.com/20250520"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:us-types="http://fasb.org/us-types/2024"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.bauschhealth.com/20250520"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20250520_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bhc-20250520_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bhc-20250520_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 5/20/2025 6:51:12 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bhc-20250520_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 74.1.4 -->
<!-- Creation date: 5/20/2025 6:51:11 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="bhc-20250520.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.331" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 20,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Bausch Health Companies Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">A1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0448205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">2150 St. Elz&#233;ar Blvd. West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Laval<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">QC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">H7L&#160;4A8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">744-6792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Shares, No Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d933207d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>bhc-20250520.xsd</File>
    <File>bhc-20250520_lab.xml</File>
    <File>bhc-20250520_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d933207d8k.htm">d933207d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d933207d8k.htm": {
   "nsprefix": "bhc",
   "nsuri": "http://www.bauschhealth.com/20250520",
   "dts": {
    "schema": {
     "local": [
      "bhc-20250520.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "bhc-20250520_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bhc-20250520_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d933207d8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-05-20_to_2025-05-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d933207d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-05-20_to_2025-05-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d933207d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "terseLabel": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bauschhealth.com//20250520/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-25-123366-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-123366-xbrl.zip
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MLN6=+\ +CWW S6H=CEPQVXU;[-;UJGLXW&SBQ4ZSV:NM:MZ8U[]02P,$%
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MGI^*ZT!47TP'1BV>_^'UDXN@D(Q;76#>==T>,1_FS4U=\@]02P,$%     @
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MEC-?;<69E1I,RS/GL9%5VWHY>_PU937'W8MYW!#D"=CJ[<?K#^1$AC1(]='
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M5\TW]"UKOM-=?G/:_XYJC]E!MPYX&_;'K24*:W0UD>1-\^;G ,I=GSN?-^H
MF@-FS(V&FR[Y1$16(V).@\./AKW3B3.PI$TJ(SDS+)8\/PL#U84CDS8X^S%?
M/;:,>JCNY[94U"K6X_ +[ A\0(EY$?V<5[BWA3/P[IBLZI>,55VJ:-6\S;TZ
M>;&[;6GR'U;9R*I9Y2^-$?[T1F6@ )PT9Y;)D:&]R*;0)CFSKBE!T"&F99:5
MIO"59<(GG4KL*J]3N%#&!2M-E45(4A'!Z,0#KM>.-KYH1Z=-$@</B9!XDM,!
M9"<2 L&_-F\:A2/J9Y$/R^_C=?!*NETCV2YU+7->XQR7D?Z@7&__SU.PO7M4
MK]NU Q>YUS9<.QT8/"EC9JNTR0=[OT)^7#ZH/SD?U!_*!WI:MGJ9H6[ZIN0?
MF::-)Z=IX^&RG2\'_R1ICJ2/2M$.%J%!EOH,2 'THZ8Z>@H."<&W=Y(B%E5<
MK-EA-C3)HVD_E."O>A$W?HLYYK86AZ>[B!&_M;3'O.>_UDM[K*;XLS]6^58[
M8&AAD2\6I2>^\XS<L[ZA_.;\]\OV[1_72WY?YW&2RK-=%3H9;Y)6Z[6FZ_X7
M:IH!2O.ZDMT(@@5=X'1-*WK\:P.FCJBKC=K]Q^QTEPVHWTM*F;J(&T] ]HRP
M,TXO%Q=X_F;NX_:SFY](:,ZV!>[V75?/FCQK+,Z=&:%9\2#L;(9LY<.L\_)I
MC_L^\S5,[CJ'R#U?M,[T%5GO-^T_;CKOR+NS]L7M._P-JZOV)?ZTU?EEI[+\
MO<]K.$K(BPL\)3WT=;A*@(1Q<T.W:'WT;_(0XXJ6_ T5QRSE]>>FIP!$I]"J
MRBJH5O"2,1R6F+F;]Q: [T@4\H?]'D\X>7/IOSV'D2ML]'-UT?1W%H!#[A-\
ME:QD_@KW*O[?_,:K_OG7UO\#4$L#!!0    ( /2AM%JH<A'&FQ,  $^(   1
M    9#DS,S(P-V1E>#$P,BYH=&WM7&MSVDC6_DX5_Z&+J6R9&N+8SF4GMN,J
M#+)A%P,%)-GL6^^'1FJ@-T+2Z&+"_OH]YW2W+A@[\<1.2*+43(*DOISN/N<Y
M5^FT,[GJG9UVK&;[K%HYG70G/>O,^M?3PX/]H]-GZA+N/],-V.GYH/V!G5^V
M!KW!Z$WM?:<[L6IL//G0L][47.F)IPLAYXOXN.^'2^[6SEBU OU;PHM%>';:
M[KXSC5?2B1?'?^R_E%Z-<5?./1A S.(:33,TS98\G$OO:>P'QP=!?,+T]=2/
M8W^I;LU\+WX:R?^*X\/L>L:7TET?3^121*PO5FSD+SG,U.QU+_MO:B$263L[
M/3^S/BWD5,8,5\Q.GYV?G3X;XI*W4?#J$2CH @7"3F+I>^R=""/\]_]:OC>#
M#13._P-)W;M(.CQZ )IP'T[?GK6M7O>=-;+:[/P#.[T8]"?I82UD+)Y& ;?%
ML>>O0A[4SJRG5\UN[_09MCL#,M^>?8/=.[OBZ[]YTR@X.3H HALX)3LZ.'K)
M<.+M?/,@\YZ'(HY9U^8+CSWV&M4L+1[(F+NL-[QC;0\A$V>'KUZ]/F MWP4!
MCECS6GB)N&N1#S+I$"!AX2>18.,$F O^]KPUZT8N-#L7W%X\]JHO>NSY\\-7
M!W>M]&&DJRUXR*["?<6X=+K'=ZSN(45ZG 2!*Y:PU\A)P,(B9,UY*.@6 GLF
MM8\H/!=)&"]@YMAG?A(R1T9V$B'218Q[#H-G;"E$++TY\V=T.?5YZ."%(T-A
MQWX8L3V\#ZLZ[[2Z[!R?(^5U;'3.DP@8IB.X&R^ D9<!]R20T/7L_;2?NKVF
M3M7*0K@.6XL(-L3AZP9,*B/FJ@WB9H-8).((E@;4,UN$,9=>]C!B4Q&OA/"(
M8#UZNAXEPY>AGP1LCT<L2H! &'S)8!Y'S$!5.DRJOFV]1M8, E]Z,4V- _7]
MI?0XJ8;TT)C#8^AZ(:9APD,#AL\;B(*'Q4UJ-_M-M4<Y2JN535(#T#KF*& "
M&>/6N3+":6#FL;T03N(*UL36 (,^V[,!*X!D>2U<VCN:,[=DFK7.0C&'8\)C
MI2/FN+N1.7X8'8>3WOZCR\*%'U8K<]]W:(W7W$WX%!9DPZJE(T+:8;4,. @A
M [7[43*;25L*SUXCDX$.A"/DH2"RI[!_]D?0A:YPYK 4N";0TOP;\)"V46U8
MHW"/..@& &0+0I'; +L;&U [4P=/@Z#AUCSO66:H\\&H;8V>@HW6:P['UK'Y
M<><N;6YIC:EAWM0.:JQE]7K#9KO=[5^FU^-ALV6NWW?;D\Z;VN'!P9.:HF?$
MHG@->_R&U0(^%T^GH> ?GTK:\&-^[4M'-VR;SB^>U-@[;1S!NE-#21F%AV"-
MMDV/_)-"G_R&LN(>LJ]EHQ.V01+@ @N2,/ C:$;GO@5"U#D3\?#7"/_"HRHH
MG/+HGV2+RDY9/WQY)U_L\?KN<<;??CM\\?<3A.'?>PB%>/T'S"(XP*Q65K^S
MGK^<@MX !E((=%*RRN.RRG3'626S:@H,<XL]A';/[[V2:1Z9:>Q=9QICY=W@
MF2;H'T<HFV<$EB[9C7_!UJQ6_I%X0AN:AV1H'J46)5* W8UYO!3+J0@C8P?E
M;,+;.+6T@1Z&49U=9U3%"VT1R;DG1+259S?:W.DZ&>:OGR 'HC-;LM?CL9?8
M:?9"=_>A^0O;IW[T2<E?7^O"'>T> \4+'K-HX2<NJLFUUEY;E!<3WASV -F"
MLW$@;#F3P"5-FQ3FK5PT%:Z_JA^7O//K^8![LDXL=5/S(6]Y+!+A-04\<T!#
M]C_P(W==)I=+X4BPO]PUL!48<B'#^ )8;AA)#6DL9:[-0G]9K10'(97(]J2L
MJSW=9&<]1QB*:]_F4YACQ>4U\?<JE!2)Q08@"#*.&.6J<@%"5P= $R(K$B0%
M$3N$@]B[KE,[]1OF-\*4(FD#)K'=!,."#8RMTE-B">[9@GP</YG&#=H]FAGC
MQHY>,#0%8S9PN:U#V.FN?C&4UVE6[MT\%@"#!8RBMAOCD]LW'$' MOU0$;R2
M\8*-U1YH(QG7#BO'X)\_4T=1>FF_G&M_3P2XU<7/@OKY$$%=R7"U<C^@4*)@
M!OI^,"&OZPT#$@8Q1 86VK3?AA75RE\%"_;E6&%<B\>'BNF70\6S=O<=7.MB
MBFJ%T7^G@9*T8MY$+&_P,][*B>)4P-I %-T57T<H&<\"G*0S8N/NOT$^GM?,
MN%3L<?S;:_I3E'7#\2VK/[%&?[7<XZ?!KSL@ZOGN 13PK^NC"$?,\^^P?9'1
ME?WK;#> RR3'+VC@YK/>*PE:($J"P _CVW3>:N$CTI+J\_@2 Y.@*X J#_:/
MX-G#$"2T1,P5KH))A',"_51GJ=PL*:9K'R!^#UK;' M)H.E4T$VGCIH#D1@X
M-4:>5MY=6F, _4.Q\%U'9&H6(%WG>+UL^H(^EIC0=9T&TY/C8*#6DE#ES/4X
M::Y8@EY2G4%Q I72,U<-DBE_Y<'T"QG@0_\:A,_T8^*3"&T9B:A:L>%,0M_%
M-JH[):MA=91OMGFDU1%FIK7:=?);@>LB7:>73WUGP*()"3N-0L]OGME=^JCT
M77]>RW6K0^KY,4KFDD3)@[ZVOUS*.$9SRE?E/0N0G/0N%<Z@F$>^B[:I<?5R
M*7,PY1P'A#1"03+E(=A.R0&5FQ!?<SM.N(L%&S-7VC&)FD0;0T0Q_+CVW6M3
M9;(M%%@GR\M/$ EF(J2F/LJ%*S@,X'M;N]%P/F%:XLEXK86*YS0ER4UN'X+0
MOP8N 818^"L!$MU0LBDWFU8K" !+,,#4KLW0JMY[J<UPDT0AK(1#76Q=E3Z7
MJ5"K2J6>J\R.NMZD4,$IX$N,B)OM<+SRMT]"--P(4M3K^U^@\Q^\D(<("$4
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M42M3404</.5K.H_B8BX&7M&6F_TW>0>>;R@S;JP=$MU'HRP(J$+"8T#0)"_
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MGAV:G@S?C<5Y_YKD-*)0=YJ]TQOV.SP])A>7(^C3OQPX+%TYQN.?$(XW>KQ
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M+3(P,C4P-3(P+GAS9%!+ 0(4 Q0    ( /2AM%J8T=+@7P8  &=&   4
M          "  2,#  !B:&,M,C R-3 U,C!?;&%B+GAM;%!+ 0(4 Q0    (
M /2AM%KO4;A IP0  !XL   4              "  ;0)  !B:&,M,C R-3 U
M,C!?<')E+GAM;%!+ 0(4 Q0    ( /2AM%K9AQ>;)Q0  )1Y   .
M      "  8T.  !D.3,S,C W9#AK+FAT;5!+ 0(4 Q0    ( /2AM%JH<A'&
MFQ,  $^(   1              "  > B  !D.3,S,C W9&5X,3 R+FAT;5!+
M 0(4 Q0    ( /2AM%I%NAVV^@\  .E'   1              "  :HV  !D
M.3,S,C W9&5X,3 S+FAT;5!+ 0(4 Q0    ( /2AM%JN"$QUT \  +5&   1
M              "  =-&  !D.3,S,C W9&5X,3 T+FAT;5!+!08     !P '
+ +L!  #25@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d933207d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bhc-20250520.xsd" xlink:type="simple"/>
    <context id="duration_2025-05-20_to_2025-05-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885590</identifier>
        </entity>
        <period>
            <startDate>2025-05-20</startDate>
            <endDate>2025-05-20</endDate>
        </period>
    </context>
    <dei:DocumentPeriodEndDate
      contextRef="duration_2025-05-20_to_2025-05-20"
      id="Hidden_dei_DocumentPeriodEndDate">2025-05-20</dei:DocumentPeriodEndDate>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-05-20_to_2025-05-20"
      id="Hidden_dei_EntityCentralIndexKey_duration_2025-05-20_to_2025-05-20">0000885590</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2025-05-20_to_2025-05-20"
      id="Hidden_dei_AmendmentFlag_duration_2025-05-20_to_2025-05-20">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_1">8-K</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-294">Bausch Health Companies Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-295">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-296">001-14956</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-297">98-0448205</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-298">2150 St. Elz&#xe9;ar Blvd. West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-299">Laval</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-300">QC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-301">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-302">H7L&#160;4A8</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_2">514</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_3">744-6792</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-305">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-306">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-307">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-308">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_4">Common Shares, No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_5">BHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-05-20_to_2025-05-20" id="Fact_6">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-05-20_to_2025-05-20" id="ixv-312">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
